Home > PJ > Contents

The Pharmaceutical Journal, August 11, 2001

Back issues

Previous  Next

Return to PJ Online Home Page

Leading Article   
   No gain without pain

News & Features   
   News

   Managing drug shortages in the NHS [more]

   Benefits of recording interventions [more]

Comment   
   Broad Spectrum: Who represents local pharmacists in the new NHS? [more]

   Letters to the Editor

Continuing Education   
   An update on risk factors for vascular disease
   »(PDF*, 50K)

Features   
   Pensions planning: A quiet revolution and What is a stakeholder pension?
   »(PDF*, 55K)

Articles   
   Where have all the medicines gone? [more]
   Proposals for enhancing the role of the community pharmacist [more]

Meetings & Conferences   

   GHP Procurement and Distribution Interest Group [more]
   Welsh Executive Annual Lecture [more]

Onlooker

The Society   
   News
   Statutory committee
   Obituaries & tributes
   
Notice-board
   Series index updated
   Branch meetings
   Future events
   Conferences
and more

Products


* PDFs require Acrobat Reader 4 or later

Front Cover Picture
Our front cover picture of a medicine production facility ties in with items this week relating to medicine shortages. An article examines the reasons for these shortages and, in a news feature, Harriet Adcock looks at how the National Health Service manages them.

Cerivastatin withdrawn
Cerivastatin is to be withdrawn world-wide because of safety concerns.

Interventions
Zoë Gross reports on how keeping intervention records can enhance the recognition of the pharmacist’s role and assist in patient care.

Vascular disease
Our continuing education article this week provides an update for pharmacists on the risk factors for vascular disease.

Role enhancement
The Adam Smith Institute has been developing a blueprint for the reform of British health care. Its proposals for the community pharmaceutical service are outlined in an article.

Pensions planning
Our special feature looks at stakeholder pensions and developments in pensions planning.

Retention fee increase
The Royal Pharmaceutical Society is to seek a 31 per cent increase in members’ retention fees in 2002. Leading article.


©The Pharmaceutical Journal